Medical Director, Clinical Development

Role: Medical Director, Clinical Development, focused on advancing Olema's breast cancer therapies, notably palazestrant in Phase 3 trials. Responsibilities include providing medical leadership for registration studies, strategic clinical planning, regulatory interactions, and cross-functional collaboration. The role involves designing and overseeing clinical protocols, evaluating safety and efficacy data, supporting regulatory submissions, and contributing to biomarker development and scientific communication. Qualifications: MD (US Board Certified) with at least 2+ years in biotech or pharma clinical development, preferably in oncology; deep understanding of breast cancer treatment and trial design; knowledge of GCP, FDA, EMA regulations; strong communication, leadership, and cross-functional influence skills. High-value biopharma specifics: focus on ER+/HER2- metastatic breast cancer, Phase 3 registration-enabling studies, biomarker integration, and collaboration with investigators and regulators. The role is based in Cambridge, MA, with up to 20% travel expected.